Marijana Golubovic, PhD
CMO Summit Chairperson
Connect with/follow on 
Marijana has 20 years of experience in Biotechnology and Biopharmaceuticals. Marijana started her career at DSM Biologics, Groningen, where she held various scientific and management positions: Scientist DSP Process Development, Head DSP Process Development, Project Manager CMO Projects, Program Manager Technology Development. In addition, she held commercial and business positions in DSM Biologics and Patheon Biologics: New Business Development and Key Account Manager. Marijana joined Sanofi in 2016, where she held various Business Management and Strategy roles. In her present role, Head Strategic Sourcing Cell and Gene Therapy, she is responsible for the Outsourcing of Cell and Gene Therapy Programs.
Marijana believes in diversity and inclusiveness and is a passionate advocate for equal pay.
Anthony Davies, Founder & CEO, Dark Horse Consulting
Anthony founded Dark Horse Consulting in 2014, bringing 20+ years of leadership experience in product, process, and manufacturing development to cell and gene therapy companies in need.
Clive Glover, General Manager of Gene Therapy, Pall Corporation
Clive leads Pall’s cell and gene therapy business and helps with setting the strategy around this fast-growing area, including investments and acquisitions.
Patti Seymour, Managing Director, BDO USA
Patti has nearly 30 years of experience in the biotechnology industry in areas such as development and commercialization, biologics and small molecule development, quality, regulatory and manufacturing, supply chain strategy, and management and operations leadership.
Sven Frie, General manager, Commercial Enterprise Solutions, Cytiva
Sven Frie is a techno-commercial leader with 25 years of experience within the biopharmaceutical industry as a service provider for end-to-end bio-manufacturing solutions, CDMO services, and project engineering/management.
Kevin Eisele, Managing Director, William Blair
Kevin is focused on Healthcare Equity Capital Markets. He has a decade-plus of experience leading and executing equity and equity-linked offerings including IPOs, Follow-Ons, PIPEs, and private placements for biotechnology companies.
Roger-Marc Nicoud, founder and CEO, Ypso-Facto
Roger has forged a 35-year successful career as an entrepreneur and influencer in our space and is a true pillar and expert in the life science industry. He brings unmatched expertise in the biopharmaceutical industry.
